Michael Petersen, MD, of Accenture Health, discusses the opioid epidemic and how data analytics can be used to break down the silos in healthcare to better care for people addicted to opioids and to prevent further spread of the epidemic.
No one is immune to the opioid epidemic—it affects people regardless of socioeconomic status and most Americans are just 1 to 2 degrees of separation from someone who has a substance abuse problem or addiction to opioids, explained Michael Petersen, MD, medical director and innovation lead of North America Opioid Epidemic Solutions Lead at Accenture Health.
In an interview with Mandi Biship, MA, CEO of Lifely Insights, Petersen discussed the opioid epidemic, the analytics opportunities, and how because the epidemic is so widespread, it is impacting productivity in the United States. He also explains how Accenture is helping to break down silos to better care for people addicted to opioids and to prevent the epidemic from getting worse.
Listen below or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Optune Lua Device in NSCLC
October 16th 2024Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer (NSCLC) that has not responded to platinum-based treatment.
Read More